Aarti Drugs
quarterly
yearly
| Particulars | Jun '21 | Sep '21 | Dec '21 | Mar '22 | Jun '22 |
|---|---|---|---|---|---|
| Revenue | 579.95 | 579.62 | 634.80 | 694.27 | 621.96 |
| Expenses | 512.68 | 518.36 | 557.40 | 620.82 | 567.37 |
| EBITDA | 67.27 | 61.26 | 77.40 | 73.45 | 54.59 |
| EBIT | 54.85 | 48.78 | 64.80 | 60.90 | 42.05 |
| Profit Before Tax | 64.68 | 56.08 | 78.69 | 70.50 | 48.03 |
| Net Profit | 48.81 | 42.59 | 58.29 | 55.34 | 34.79 |
| Financial Ratios | |||||
| Operating Profit Margin | 11.60% | 10.57% | 12.19% | 10.58% | 8.78% |
| Net Profit Margin | 8.42% | 7.35% | 9.18% | 7.97% | 5.59% |
| Earning Per Share (Diluted) | 5.25 | 4.60 | 6.29 | 5.98 | 3.76 |
| Dividends Per Share | NA | 1.00 | NA | NA | NA |
